Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Gray Nancy Ryan, Director. Insider active across 1 company, notably Ligand Pharmaceuticals INC. In total, 7 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €72k. Activity tracked since 4 June 2021. The latest transaction was disclosed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
7 of 7 declarations
Nancy Ryan Gray is a Board Member at LIGAND PHARMACEUTICALS INC. She plays a key role in the governance of the company, bringing her expertise in biopharmaceuticals. Her role is essential in ensuring compliance and transparency in operations.